Log In
BCIQ
Print this Print this
 

Suprep (Eziclen/Izinova) (BLI-800)

  Manage Alerts
Collapse Summary General Information
Company Braintree Laboratories Inc.
DescriptionMixture of sodium, magnesium and potassium sulfates
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Gastrointestinal (unspecified)
Indication DetailsCleanse bowel prior to colonoscopy
Regulatory Designation
PartnerIpsen Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/19/2009

Undisclosed

0

Undisclosed

Get a free BioCentury trial today